Rankings
▼
Calendar
SLDB (Solid Biosciences Inc.) Stock Financials & Earnings | Market Cap Arena
SLDB
Solid Biosciences Inc.
Mkt Cap
$644M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$167M
EPS (TTM)
-$2.29
Free Cash Flow (TTM)
-$133M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q3 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q4 22
$0
$0
-$35M
Q1 23
$0
$0
-$32M
Q2 23
$0
$0
-$27M
Q3 23
$0
$0
-$23M
Q4 23
$0
$0
-$22M
Q1 24
$0
-$327K
-$27M
Q2 24
$0
$0
-$28M
Q3 24
$0
$0
-$35M
Q4 24
$0
$0
-$40M
Q1 25
$0
-$407K
-$40M
Q2 25
$0
-$386K
-$42M
Q3 25
$0
$0
-$48M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q4 22
79.5x
—
Q1 23
104.4x
—
Q2 23
—
—
Q3 23
—
—
Q4 23
—
—
Q1 24
—
—
Q2 24
—
—
Q3 24
—
—
Q4 24
—
—
Q1 25
—
—
Q2 25
—
—
Q3 25
—
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q4 22
-$34M
-$35M
Q1 23
-$28M
-$29M
Q2 23
-$27M
-$28M
Q3 23
-$18M
-$18M
Q4 23
-$21M
-$21M
Q1 24
-$25M
-$25M
Q2 24
-$21M
-$22M
Q3 24
-$24M
-$24M
Q4 24
-$30M
-$30M
Q1 25
-$32M
-$32M
Q2 25
-$37M
-$38M
Q3 25
-$33M
-$34M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q4 22
$856K
Q1 23
$506K
Q2 23
$536K
Q3 23
$383K
Q4 23
$90K
Q1 24
$149K
Q2 24
$286K
Q3 24
$15K
Q4 24
$204K
Q1 25
$126K
Q2 25
$377K
Q3 25
$85K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q4 22
-100.0%
+58.5%
Q1 23
-100.0%
+17.3%
Q2 23
-100.0%
-14.9%
Q3 23
—
+9.4%
Q4 23
—
-35.6%
Q1 24
—
-16.1%
Q2 24
—
+3.5%
Q3 24
—
+52.2%
Q4 24
—
+79.2%
Q1 25
—
+49.1%
Q2 25
—
+50.0%
Q3 25
—
+36.6%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q4 22
$2M
—
Q1 23
$2M
—
Q2 23
$2M
—
Q3 23
$2M
—
Q4 23
$2M
—
Q1 24
$2M
—
Q2 24
$2M
—
Q3 24
$3M
—
Q4 24
$4M
—
Q1 25
$3M
—
Q2 25
$3M
—
Q3 25
$4M
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q4 22
$21M
$8M
Q1 23
$25M
$7M
Q2 23
$20M
$7M
Q3 23
$17M
$6M
Q4 23
$15M
$7M
Q1 24
$19M
$8M
Q2 24
$19M
$8M
Q3 24
$27M
$8M
Q4 24
$31M
$9M
Q1 25
$31M
$9M
Q2 25
$32M
$9M
Q3 25
$39M
$9M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 22
$155M
$58M
$214M
Q1 23
$165M
$21M
$186M
Q2 23
$92M
$69M
$160M
Q3 23
$49M
$94M
$143M
Q4 23
$74M
$50M
$124M
Q1 24
$118M
$88M
$206M
Q2 24
$96M
$94M
$190M
Q3 24
$64M
$107M
$171M
Q4 24
$80M
$69M
$149M
Q1 25
$211M
$96M
$307M
Q2 25
$139M
$129M
$268M
Q3 25
$61M
$175M
$236M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q4 22
8M
+6.5%
Q1 23
20M
+143.9%
Q2 23
20M
+0.5%
Q3 23
20M
+2.0%
Q4 23
29M
+44.7%
Q1 24
38M
+31.5%
Q2 24
41M
+7.3%
Q3 24
41M
+1.2%
Q4 24
54M
+29.3%
Q1 25
66M
+23.8%
Q2 25
94M
+41.9%
Q3 25
94M
+0.3%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 15
—
—
FY 16
—
—
FY 17
$0
60
FY 18
$0
111
FY 19
$0
121
FY 20
$0
70
FY 21
$131K
104
FY 22
$93K
87
FY 23
$0
88
FY 24
$0
100
marketcaparena.com